Biotricity (BTCY) Institutional Ownership $0.41 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Biotricity (NASDAQ:BTCY)CurrentInstitutional OwnershipPercentage3.89%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$204.97KNumber ofInstitutional Sellers(last 12 months)0 Get BTCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Biotricity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTCY Institutional Buying and Selling by Quarter Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Biotricity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2024AE Wealth Management LLC97,751$88K0.0%N/A0.452% 4/19/2024 Advisor Resource Council79,070$117K0.0%N/A0.839% 10/30/2023Strengthening Families & Communities LLC48,263$103K0.0%-83.3%0.563% 10/11/2023AE Wealth Management LLC41,684$89K0.0%-83.3%0.486% (Data available from 1/1/2016 forward) BTCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTCY shares? During the previous two years, the following institutional investors and hedge funds held shares of Biotricity shares: Advisor Resource Council ($117K), and Strengthening Families & Communities LLC ($103K), AE Wealth Management LLC ($88K).Learn more on BTCY's institutional investors. What percentage of Biotricity stock is owned by institutional investors? 3.89% of Biotricity stock is owned by institutional investors. Learn more on BTCY's institutional investor holdings. Which institutional investors have been buying Biotricity stock? The following institutional investors have purchased Biotricity stock in the last 24 months: AE Wealth Management LLC ($97.75K), and Advisor Resource Council ($79.07K). How much institutional buying is happening at Biotricity? Institutional investors have bought a total of 176,821 shares in the last 24 months. This purchase volume represents approximately $204.97K in transactions. Which Biotricity major shareholders have been selling company stock? The following institutional investors have sold Biotricity stock in the last 24 months: Strengthening Families & Communities LLC ($241.31K), and AE Wealth Management LLC ($208.42K). How much institutional selling is happening at Biotricity? Institutional investors have sold a total of 449,728 shares in the last 24 months. This volume of shares sold represents approximately $962.42K in transactions. Related Companies Lucid Diagnostics Major Shareholders Sharps Technology Major Shareholders Co-Diagnostics Major Shareholders Apyx Medical Major Shareholders Allurion Technologies Major Shareholders SurgePays Major Shareholders Neuronetics Major Shareholders DarioHealth Major Shareholders Outset Medical Major Shareholders Femasys Major Shareholders This page (NASDAQ:BTCY) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.